Italy’s Stamicarbon, part of engineering group Maire Tecnimont, has been selected to license its urea technology for a project in Sub-Saharan Africa. The melt and...

US chemical producer Huntsman has entered a definitive agreement to sell its Textile Effects division to Pratteln, Switzerland-based Archroma, a portfolio company of...

Gilead Sciences has agreed to acquire MiroBio, a privately held UK biotech focused on treating inflammatory diseases, for about $405 million in cash.

Borealis has reaffirmed the suspension of construction on a new propane dehydrogenation (PDH) plant at Kallo, Belgium. The Vienna-based group cited “serious allegations”...

Amgen is beefing up its inflammatory diseases portfolio with an agreement to buy US biopharma ChemoCentryx for roughly $3.7 billion. The deal gives Amgen access to...

Pfizer is paying $5.4 billion to acquire Global Blood Therapeutics (GBT), a drugmaker specialized in treating blood disorders. It is one of several deals the company has...

In addition to the transformation towards a climate-neutral chemical industry and the perennial topic of digitalization, the current global political situation also poses...

Engineering companies McDermott International and KBR have entered into a global licensing agreement to provide integrated solutions for KBR's proprietary ammonia...

A recession is headed for Europe that will be deeper and last longer than the financial crisis of 2008, Markus Steilemann, CEO of engineering plastics producer Covestro...

French biopharma Ipsen and US-based Marengo Therapeutics have formed a strategic partnership that aims to advance two of Marengo’s preclinical immuno-oncology candidates...